PATIENT REPORTED OUTCOMES
Development of patient-reported outcomes and patient preference measures
Expert advice on effective use of validated and reliable measures.
We ensure outcomes provide clarity of functionality, patient interaction with devices for optimal usage and better psychosocial functioning and quality of life.
Leading clinical trials and other research to assess quality of life and patient-reported outcomes of therapies, devices and novel interventions
We employ rigorous and robust qualitative and quantitative methodologies
We provide high quality tailored research services and health psychology expertise
We lead psychosocial investigation in clinical trials to complement biomedical and safety outcomes
New and higher regulatory standards have led to human factors and patient-reported outcome gaps in product submission
Provide high quality tailored human factors assessment and research services in evidence submissions, patient preference outcomes and patient engagement
Ensure assessments span age, gender, ethnicity, socio-economic status and health literacy using validated and reliable measures
Ensure outcomes provide clarity of functionality, patient interaction with devices for optimal usage and better psychosocial functioning and quality of life
KEY OPINION LEADERS
Research advisory boards
Industry advisory boards
Clinical research funding boards
Community and individual approach to preventing diseases, improving quality of life and reducing social inequalities.
Professor Katharine Barnard-Kelly PhD, Practitioner Psychologist (HCPC Registration: PYL02075)
AT THE HELM
Professor Katharine Barnard PhD, Chartered Health Psychologist, specializes in human factors assessment and the psychosocial impact of disease. She has a longstanding research interest in human factors, patient engagement and quality of life assessment. Her extensive evidence-based, theory-driven research portfolio has provided valuable insights into factors contributing to therapy choice, technology uptake and quality of life; behavioural interventions and the far-reaching impact of disability and disease on individuals and their family members.
Prof Barnard is currently leading on human factors assessment, patient preference, trade-offs and psychosocial assessment of diabetes technologies; she is an Expert Adviser to NICE; a close collaborator with the FDA and is the UK psychological lead on research to enhance patient engagement, optimised self-management heath behaviours, device functionality and human interaction thereof.
Professor Barnard has collaborated and consulted with the Johnson & Johnson Diabetes Care Companies (including Animas Corp, LifeScan Inc, & the Johnson & Johnson Diabetes Institute) over the past several years, working specifically with us as an Expert Key Opinion Leader, as a keynote speaker at international scientific and professional education events and in a research capacity. A member of our Animas Academy scientific advisory board, Professor Barnard provides diabetes-related specialist advice, making a valuable contribution to the team. Her knowledge and experience in de-mystifying the complex area of psychological interventions and psychosocial aspects of diabetes as a chronic disease has been invaluable to my team.
Brian Levy MD, FACE
Chief Medical Officer - Johnson & Johnson Diabetes Care
Please find the resources below produced by Barnard Health and freely available and published